Evangeline Schott

Evangeline Schott

Auto-generated profile, based on publicly available information

Evangeline Schott

Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine and The Davis Heart and Lung Research Institute The Ohio State University Columbus Ohio USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2025 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
MYMichael J. Yaeger
Michael J. Yaeger
TNTyson Ngatikaura
Tyson Ngatikaura
NZNatali Zecchino
Natali Zecchino
HLHannah B. Lovins
Hannah B. Lovins
ESEvangeline Schott
Evangeline Schott
KGKymberly M. Gowdy
Kymberly M. Gowdy
Ozone (O3) is an air pollutant that induces pulmonary inflammation and injury, leading to increased susceptibility and exacerbation of chronic lung diseases. Furthermore, ambient O3 concentrations are expected to rise with increasing global temperatures. Docosahexaenoic acid (DHA) is an omega-3 polyunsaturated fatty acid found primarily in oily fish that reduces inflammation and enhances the resolution of inflammation. This is attributed partially to DHA-derived oxylipins termed specialized proresolving mediators that have antiinflammatory and/or proresolving properties. However, whether dietary DHA protects the lungs from O3-induced inflammation and injury is unclear. We hypothesized that dietary DHA supplementation increases pulmonary specialized proresolving mediators and thereby decreases O3-induced pulmonary inflammation. To test this, C57BL/6J mice were fed a control diet or a DHA-enriched diet (2% kcal from DHA) for 6 weeks, exposed to filtered air or 1 ppm O3 for 3 hours (comparable with an O3 action day for humans), and necropsied 24 or 48 hours after exposure. DHA supplementation reduced airspace neutrophilia, decreased cytokine production, and promoted transcriptomic signatures for leukocyte chemotaxis and fatty acid oxidation. Furthermore, dietary DHA increased pulmonary DHA and its oxylipins while decreasing proinflammatory omega-6 polyunsaturated fatty acids and their oxylipins. Oropharyngeal aspiration of DHA oxylipins monohydroxylated 14-hydroxy-DHA and maresin 1 decreased O3-induced airspace neutrophilia and reduced bone marrow–derived macrophage production of neutrophil chemokines Cxcl1 and Cxcl2. These findings reveal that dietary DHA protects the lungs from O3 exposure by driving monohydroxylated 14-hydroxy-DHA and maresin 1 production, which reduces neutrophil-recruiting chemokine production by macrophages. This pathway highlights a potential therapeutic dietary approach for mitigating air pollution–induced pulmonary inflammation.

27 May 2025 in The FASEB Journal
Verified
Journal Article
Open access
MYMichael J. Yaeger
Michael J. Yaeger
TNTyson Ngatikaura
Tyson Ngatikaura
NZNatali Zecchino
Natali Zecchino
KDKatelyn Dunigan‐Russell
Katelyn Dunigan‐Russell
HLHannah B. Lovins
Hannah B. Lovins
KGKymberly M. Gowdy
Kymberly M. Gowdy
Ozone (O 3 ) is a toxic air pollutant that causes pulmonary inflammation, neutrophil recruitment, and lung injury. Part of the inflammatory response to O 3 includes altered expression of formyl peptide receptor 2 (ALX/FPR2), a G protein‐coupled receptor expressed primarily in immune cells. ALX/FPR2 is considered either anti‐inflammatory/proresolving or proinflammatory depending on its ligands, which include lipoxin A4 or serum amyloid A (SAA). While the anti‐inflammatory/proresolving lipoxin A4 ligand has been well studied, there remains a significant knowledge gap in the interaction between proinflammatory SAA and ALX/FPR2. To date, SAA has been shown to increase neutrophil recruitment through ALX/FPR2 and is increased systemically after O 3 exposure. However, it is unclear if pulmonary SAA signals through ALX/FPR2 during the O 3 ‐induced inflammatory response. We hypothesized that ALX/FPR2‐SAA signaling is required to initiate neutrophil recruitment to the lungs following O 3 exposure. To test this hypothesis, ALX/FPR2 wild type (FPR2 +/+ ) or knockout (FPR2 −/− ) mice were exposed to filtered air (FA) or 1 ppm O 3 for 3 h. Pulmonary inflammation was assessed 6, 24, and 48 h following O 3 exposure. FPR2 −/− mice exhibited impaired neutrophil recruitment at 6 and 24 h after O 3 exposure. In addition, FPR2 −/− mouse pulmonary SAA expression was significantly increased after O 3 exposure compared to FPR2 +/+ mice. FPR2 +/+ mice dosed with SAA via oropharyngeal aspiration had increased pulmonary neutrophils, while neutrophils were not increased in FPR2 −/− mice. Taken together, these data indicate that ALX/FPR2 may contribute to SAA‐induced pulmonary neutrophilia following O 3 exposure.

9 December 2025 in Current Allergy and Asthma Reports
Verified
Journal Article
Closed access
SCSamuel J. Cochran
Samuel J. Cochran
ESEvangeline Schott
Evangeline Schott
TNTyson Ngatikaura
Tyson Ngatikaura
Megan BallingerMegan Ballinger
Megan Ballinger
KGKymberly M. Gowdy
Kymberly M. Gowdy

2 January 2024
Verified
Book Chapter
Closed access
PDF file
SCSamuel J. Cochran
Samuel J. Cochran
ESEvangeline Schott
Evangeline Schott
BSBrett Saunders
Brett Saunders
KGKymberly M. Gowdy
Kymberly M. Gowdy
Though a percentage of lung diseases can be attributed to genetic variation, the incidence and progression of lung diseases are significantly influenced by exposure to environmental toxicants. Toxicant exposure through the inhalation route is of primary concern for lung disease pathology. Airborne toxicants can be grouped into three main categories: gaseous phase (e.g., ozone, CO); volatile organic compounds (e.g., formaldehyde, benzene); and respirable particulate matter (e.g., asbestos, PM2.5). Lung disease can result from material accumulation in the airways, as in a variety of pneumoconioses. It can also result from unrepaired DNA damage from exogenous radiation or endogenous oxidative stress, as in many lung cancers. Finally, lung disease can result from aberrant immune cell recruitment and dysfunction leading to adverse airway responses, as in asthma and chronic obstructive pulmonary disease (COPD). Understanding and alleviating the burden of these varied diseases requires an investigation of the sources and risks of the exposures inextricably tied to their pathophysiology. Here we describe epidemiology and pathophysiology for some of the most prevalent lung diseases, as well as the mechanisms of action and sources of common inhalable toxicants. <!----> <!----> <!----> <!---->

13 May 2026 in The FASEB Journal
Verified
Journal Article
Open access
LLLaura A. Leuenberger
Laura A. Leuenberger
JBJoseph S. Bednash
Joseph S. Bednash
ESEvangeline Schott
Evangeline Schott
CMCarmen Mikacenic
Carmen Mikacenic
EMEric D. Morrell
Eric D. Morrell
KGKymberly M. Gowdy
Kymberly M. Gowdy
Acute Respiratory Distress Syndrome (ARDS), a heterogeneous syndrome of hypoxic respiratory failure secondary to dysregulated pulmonary inflammation, is caused by diverse insults. This heterogeneity presents challenges for mechanistic and therapeutic research, as evidenced by conflicting results from trials of n−3 polyunsaturated fatty acid (PUFA) supplementation for ARDS. PUFAs and downstream oxylipins are important to pulmonary inflammation but are not well defined in ARDS. We hypothesized that differences in fatty acid metabolism, as measured by levels of n−3 and n−6 PUFAs and oxylipins, are associated with differences in ARDS outcomes, inflammation, and causes. To test this, PUFAs/oxylipins were measured by LC MS/MS in plasma samples from 90 patients with ARDS. Pro‐inflammatory cytokines and chemokines IL‐6 and IL‐8 were measured by ELISA. Multivariable linear regressions modeled the relationship between PUFAs/oxylipins, inflammation, and ARDS mortality, severity, and cause. Multiple n−3 and n−6 PUFA‐derived oxylipins were decreased in severe ARDS. We did not detect differences in PUFAs/oxylipins by mortality. PUFAs/oxylipins varied by cause of ARDS, especially between patients with sepsis and those with trauma. Furthermore, specific oxylipins were associated with IL‐6 and IL‐8. As we observed that oxylipins varied by disease severity and underlying cause, these metabolites may function as biomarkers and suggest dysregulated mechanisms of lung repair. Furthermore, while oxylipins are derived from PUFAs, differences in PUFAs did not directly correlate with changes in oxylipins, suggesting altered lipid metabolism as a mechanism. Further consideration of differences in lipid metabolism in ARDS could identify subgroups with differential responses to n−3 PUFA supplementation or other therapies.

4 June 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SCSamuel J. Cochran
Samuel J. Cochran
BSBrett Saunders
Brett Saunders
ESEvangeline Schott
Evangeline Schott
KDKatelyn Dunigan-Russell
Katelyn Dunigan-Russell
GHGrace M. Hutton
Grace M. Hutton
KGKymberly M. Gowdy
Kymberly M. Gowdy
Ozone (O 3 )-driven pulmonary inflammation is partly regulated by damage associated molecular patterns (DAMPs) binding to scavenging receptors (SRs). However, how SRs and DAMPs regulate O 3 -induced pulmonary inflammation remains incompletely understood. CD163 is a SR responsible for clearing cell free hemoglobin (CFH), a DAMP which accumulates during acute pulmonary injury and is associated with worsening respiratory outcomes. We hypothesized that increased CD163 is necessary for reducing CFH levels and resolving O 3 -induced pulmonary injury. To test this hypothesis, we defined CD163 and CFH responses to O 3 exposure in C57BL/6N (WT) and CD163 deficient ( Cd163 -/- ) mice, as well as in human bronchoalveolar lavage fluid (BALF). In WT mice, lung Cd163 expression was significantly increased by O 3 during peak inflammation and declined 24 hours post exposure. Human exposure studies revealed a diversity of Cd163 expression and a reduction of CFH following O 3 exposure, suggesting regulation of this pathway in humans. When compared to WT mice, Cd163 -/- mice had augmented O 3 -induced pulmonary injury, inflammation, and oxidative stress. Further, the antioxidant EUK-134 did not reduce O 3 -induced pulmonary oxidative stress in Cd163 -/- mice, suggesting a role for CD163 in the pulmonary response to oxidative insults. Furthermore, compared to WT controls, Cd163 -/- mice receiving an oropharyngeal aspiration of CFH had a significant increase in airspace inflammation. Combined, these findings suggest that CD163 mediated clearance of CFH is involved in resolving O 3 -induced pulmonary injury, inflammation, and oxidative stress. New & Noteworthy: Ozone (O 3 ) is known to induce damage associated molecular patterns (DAMPs) which drive lung inflammation. The scavenging receptor, CD163, binds and clears the DAMP cell free hemoglobin (CFH), which accumulates during sterile lung injury. Our findings indicate that O 3 exposure alters CD163 expression in the lung and that mice lacking Cd163 expression have more lung inflammation. Our data indicate that CD163 serves a protective role in response to acute O 3 exposure perhaps through CFH clearance.